3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
A clinical breakdown of Vyvanse (lisdexamfetamine) adverse events by frequency, severity, and patient phenotype, using trial data, FDA labeling, and FAERS reports to guide prescribing and monitoring decisions.
A data-driven breakdown of Vyvanse (lisdexamfetamine) adverse event rates drawn from key ADHD and BED trials, FDA labeling, FAERS reports, and post-market literature, with specific incidence numbers per 200-word section.
A guide to the rare but serious adverse events associated with Vyvanse (lisdexamfetamine), covering cardiovascular risks, psychiatric complications, serotonin syndrome, and FDA safety data with primary-source citations.